切换至 "中华医学电子期刊资源库"
高级检索
中华妇幼临床医学杂志(电子版)

中华妇幼临床医学杂志(电子版) ›› 2012, Vol. 08 ›› Issue (06) : 696 -699. doi: 10.3877/cma.j.issn.1673-5250.2012.06.005

所属专题： 文献；

论著

不同剂量及疗程米非司酮治疗大鼠子宫内膜异位症的疗效
胡瑜凌1, 乔林1, 杨琳1, 钟兰萍1, 徐克惠1,*,*()   
  1. 1. 610041　成都，四川大学华西第二医院妇产科
  • 收稿日期:2012-08-01 修回日期:2012-11-01 出版日期:2012-12-01
  • 通信作者: 徐克惠

Effect of Different Doses and Courses of Mifepristone in the Treatment of Rats' Endometriosis

Yu-ling HU1, Lin QIAO1, Lin YANG1, Lan-pin ZHONG1, Ke-hui XU1()   

  1. 1. Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China
  • Received:2012-08-01 Revised:2012-11-01 Published:2012-12-01
  • Corresponding author: Ke-hui XU
  • About author:
    (Corresponding author: XU Ke-hui, Email: )
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

胡瑜凌, 乔林, 杨琳, 钟兰萍, 徐克惠. 不同剂量及疗程米非司酮治疗大鼠子宫内膜异位症的疗效[J]. 中华妇幼临床医学杂志(电子版), 2012, 08(06): 696-699.

Yu-ling HU, Lin QIAO, Lin YANG, Lan-pin ZHONG, Ke-hui XU. Effect of Different Doses and Courses of Mifepristone in the Treatment of Rats' Endometriosis[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2012, 08(06): 696-699.

目的

探讨不同剂量、不同疗程的米非司酮(mifepristone)对减小子宫内膜异位症(EMs)病灶的疗效。

方法

建立EMs大鼠模型，将建模成功的79只大鼠随机分为高剂量组[米非司酮剂量为2.604 mg/(kg·d)]、低剂量组[米非司酮剂量为1.041 mg/(kg·d)]及对照组(1 mL花生油)，治疗期内死亡7只；将3组再按不同疗程分为20 d亚组，30 d亚组，40 d亚组，观察用药20 d，30 d及40 d时异位病灶体积的减小率，从而判断治疗的有效性。

结果

高剂量组及低剂量组分别与对照组疗效比较，异位病灶体积均显著减小，差异均有统计学意义(P<0.05)；而低剂量组与高剂量组的异位病灶体积减小率比较，差异无统计学意义(P＝0.662)，用药20 d，30 d及40 d时病灶减小率比较，差异亦无统计学意义(P＝0.559，0.145，0.057)。

结论

米非司酮可抑制EMs异位病灶的生长，低剂量组与高剂量组抑制趋势无显著差异，而且延长治疗周期，亦不能增强该药对异位内膜生长的抑制作用。

关键词: 子宫内膜异位症, 米非司酮, 大鼠
Objective

To investigate the effect of different dosages and different treatment methods of mifepristone in rat's endometriosis(EMs).

Methods

A total of 79 rats were selected to establishment of models of EMs, and were randomly divided into high-dose group[dosages of 2.604 mg/(kg·d)], low-dose group[dosages of 1.041 mg/(kg·d)], control group(placebo of 1 mL peanut oil)to determine the drugs effects of the ectopic lesions reduce by medication. There were 7 rats died during treatment period. According to different courses of treatment 20 days, 30 days and 40 days, 72 rats were divided into 9 sub-groups to determine the effectiveness of treatment.

Results

After treatment of mifepristone, ectopic lesions of EMs were significantly reduced than those before treatment in low-dose group and high-dose group (P<0.05); in low-dose group and high-dose group there were significance difference than those in control group (P<0.05); however, curative effects of mifepristone between low-dose group and high-dose group (P=0.662) or different courses of treatment 20 days, 30 days and 40 days subgroups had no statistically significant difference (P=0.559, 0.145, 0.057).

Conclusions

Mifepristone could inhibit the growth of EMs ectopic lesions. There was no statistically significant difference to treatment models of EMs rats by medication dosages of 2.604 mg/(kg·d), 1.041 mg/(kg·d) or different courses of treatment by medication 20 days, 30 days and 40 days subgroups.

Key words: endometriosis, mifepristone, rat
图1 大鼠EMs模型的透明囊泡(异位病灶)
Figure 1 Transparent vesicles model of EMs rat (Ectopic lesions)
图2 大鼠EMs模型的紫蓝色囊泡(异位病灶)
Figure 2 Violet blue vesicles model of EMs rat(Ectopic lesions)
图3 同时具有一层子宫内膜柱状腔上皮细胞和子宫内膜间质细胞(HE染色，10×10)
Figure 3 Endometrial columnar luminal epithelial cells and endometrial stromal cells(HE，10×10)
表1 3组及其亚组的异位病灶体积减小率比较(mm3，±s)
Table 1 Comparison of reduced rate of each group lesion volume (mm3，±s)
病灶减小率(%) 低剂量组 高剂量组 对照组 合计(只)
20 d亚组 52.03±45.33ab 56.34±43.06ab －73.49±139.50 25
30 d亚组 36.58±35.21ab 55.36±27.69ab －80.64±78.22 23
40 d亚组 74.35±18.67ab 76.29±23.41ab －23.50±101.47 24
合计(只) 25 23 24 72
[1]
Kettel LM, Murphy AA, Morales AJ, et al. Preliminary report on the treatment of endometriosis with low dose mifepristone (RU 486)[J]. Am J Obstet Gynecol, 1998, 178:1151-1156.
[2]
Kettel LM, Murphy AA, Morales AJ, et al. Treatment of endometriosis with the antiprog-esterone mifepristone (RU486)[J]. Fertil Steril, 1996, 65:23-28.
[3]
Kettel LM, Murphy AA, Mortola JF, et al. Endocrine responses to long-term administration of the antiprogesterone RU486 in patient with pelvic endometriosis[J]. Fertil Steril, 1991, 56:402-407.
[4]
Shang HL, Li GY, Liu HH, et al. Laparoscopic surgery combined mifepristone treatment for ovarian endometrial cyst of 55 Cases[J/CD]. Chin J Gynecol Obstet Pediatr:Electron Ed, 2005, 1(2):175-176.
[5]
Pelch KE, Sharpe-Timms KL, Nagel SC.Mouse model of surgically-induced endometriosis by auto-transplantation of uterine tissue[J]. Visual Exp, 2012, 59:3388-3396.
[6]
Grümmer R. Animal models in endometriosis research[J].Human Reprod Update, 2006, 12(5):641-649.
[7]
Matsuzaki S, Canis M, Darcha C, et al. Cyclooxygenase-2 selective inhibitor prevents implantation of eutopic endometrium to ectopic sites in rats[J]. Fertil Steril, 2004, 82(6):1609-1615.
[8]
Rene V, Francisco Q, Rosa B, et al. Intraperitoneal recombinant interleukin-2 activates leuko cytes in rat endometriosis[J]. J Reprod Immunol, 2007, 74:124-132.
[9]
Rosa-e-Silva JC, Garcia SB, Rosa-e-Silva AC., et al. Increased cell proliferation in experimentally induced endometriosis in rabbits[J]. Fertil Steril, 2010, 93(5):1637-1642.
[10]
Carbonelli Esteve JL, Boza OP, Riverón Cobo AM, et al. Treatment with 5 mg or 25 mg of mifepristone daily for six months. A randomized double-blind study[J]. Progr Obstet Gynecol, 2012, 55:51-59.
[11]
Yang MY, Rajamahendran R. Involvementofapoptosis in the atresia of nonovulatory follicle during the bovine estrous cycle[J].Biol Reprod, 2000, 63(5):1313-1321.
[12]
rentice A, Deary A, Goldbeck-Wood S, et al. Gonadotrophin-releasing hormone analogues for pain associated with endometriosis[J].(Cochrane Review)In: The Cochrane Library, 2007, Issue 2.
[13]
Irving M, Spitz SM, Chabbert-Buffet N, et al.Management of patients receiving long-term treatment with mife- pristine[J]. Fertil Steril, 2005(6):1720-1726.
[1] 张巧梅, 孙小平, 李冠胜, 邓扬嘉. 针灸对大鼠呼吸机相关性肺炎中性粒细胞归巢及胞外诱捕网的影响[J]. 中华危重症医学杂志(电子版), 2023, 16(04): 265-271.
[2] 罗丹, 孔为民, 陈姝宁, 赵小玲, 谢云凯. 子宫内膜异位症患者在位及异位内膜上皮细胞-间充质转化相关生物标志物的变化[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 530-539.
[3] 张晓燕, 肖东琼, 高沪, 陈琳, 唐发娟, 李熙鸿. 转录因子12过表达对脓毒症相关性脑病大鼠大脑皮质的保护作用及其机制[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 540-549.
[4] 靳茜雅, 黄晓松, 谭诚, 蒋琴, 侯昉, 李瑶悦, 徐冰, 贾红慧, 刘文英. 产前他克莫司治疗对先天性膈疝大鼠病理模型肺血管重构的影响[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 428-436.
[5] 朱美缔, 王树明, 郭思佳, 井维斌, 马明明, 刘锐. 丙戊酸钠对50%总体表面积Ⅲ度烫伤大鼠肺功能保护作用的研究[J]. 中华损伤与修复杂志(电子版), 2023, 18(01): 47-52.
[6] 魏强, 张明祥, 陈强谱, 孙宝房. 增味小承气汤对梗阻性黄疸大鼠胃肠道动力的影响[J]. 中华普通外科学文献(电子版), 2023, 17(04): 267-270.
[7] 李义亮, 买买提·依斯热依力, 王永康, 王志, 赛甫丁·艾比布拉, 李赞林, 克力木·阿不都热依木. 聚丙烯和生物补片对腹壁疝大鼠腹横筋膜组织氧化应激、MMPs及TIMPs的影响[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(02): 125-129.
[8] 卢强, 杨丽斐, 刘康, 余佳薇, 任璐, 张谞丰, 吕毅. 供肝免冲洗灌注的大鼠肝移植实验研究[J]. 中华肝脏外科手术学电子杂志, 2023, 12(01): 103-107.
[9] 杨蕴钊, 周诚, 石美涵, 赵静, 白雪源. 人羊水间充质干细胞对膜性肾病大鼠的治疗作用[J]. 中华肾病研究电子杂志, 2023, 12(04): 181-186.
[10] 隆昱洲, 柳华, 张云茜, 李兴统, 范云虎, 尚正良, 宋镇妤, 罗丽华. 依达拉奉预适应延长急性缺血性脑卒中溶栓时间窗的研究及ROS/TXNIP/NLRP3通路参与机制的探讨[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(02): 65-74.
[11] 萨仁高娃, 张英霞, 邓伟, 闫诺, 樊宁. 超声引导下鼠肝消融术后组织病理特征的变化规律及影响[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 394-398.
[12] 王小红, 钱晶, 翁文俊, 周国雄, 朱顺星, 祁小鸣, 刘春, 王萍, 沈伟, 程睿智, 秦璟灏. 巯基丙酮酸硫基转移酶调控核因子κB信号介导自噬对重症急性胰腺炎大鼠的影响及机制[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 422-426.
[13] 王丁然, 迟洪滨. 自身免疫甲状腺炎对子宫内膜异位症患者胚胎移植结局的影响[J]. 中华临床医师杂志(电子版), 2023, 17(06): 682-688.
[14] 王宁, 吴慢莉, 杨东霞. 代谢组学生物标志物：子宫内膜异位症诊疗的新靶点[J]. 中华临床医师杂志(电子版), 2022, 16(12): 1280-1283.
[15] 戚晓阳, 杨平, 杜忠秋, 邱旭升, 汤黎明, 陈一心. 袖状胃切除术对肥胖合并2型糖尿病大鼠模型骨密度的影响[J]. 中华肥胖与代谢病电子杂志, 2023, 09(02): 102-108.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号